The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1

Jenal, M; Batliner, J; Reddy, V A; Haferlach, T; Tobler, A; Fey, M F; Torbett, B E; Tschan, M P (2010). The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1. Leukemia, 24(5), pp. 1073-6. Basingstoke: Nature Publishing Group 10.1038/leu.2010.26

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Tobler, Andreas (B), Fey, Martin, Tschan, Mario Paul

ISSN:

0887-6924

Publisher:

Nature Publishing Group

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:08

Last Modified:

29 Mar 2023 23:31

Publisher DOI:

10.1038/leu.2010.26

PubMed ID:

20200559

Web of Science ID:

000277591500025

URI:

https://boris.unibe.ch/id/eprint/671 (FactScience: 200342)

Actions (login required)

Edit item Edit item
Provide Feedback